Skip to content
GenoLensGenoLens

SPINK5

Chr 5q32

serine peptidase inhibitor Kazal type 5

Aliases:
VAKTI, LEKTI, LETKI, NETS, NS
MANE:
ENST00000256084.8

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • COVID-19 research

    BIALLELIC, autosomal or pseudoautosomal
  • Ichthyosis and erythrokeratoderma

    BIALLELIC, autosomal or pseudoautosomal
  • Palmoplantar keratodermas

    BIALLELIC, autosomal or pseudoautosomal
  • Primary immunodeficiency or monogenic inflammatory bowel disease

    BIALLELIC, autosomal or pseudoautosomal
  • Severe multi-system atopic disease with high IgE

    BIALLELIC, autosomal or pseudoautosomal
  • Epidermolysis bullosa and congenital skin fragility

    BIALLELIC, autosomal or pseudoautosomal
  • Monogenic hearing loss

Disease associations (Open Targets)

  • Netherton syndrome

    0.80
  • ichthyosis linearis circumflexa

    0.57
  • erythematosquamous dermatosis

    0.37
  • seborrheic dermatitis

    0.37
  • atopic IgE-mediated allergic disorder

    0.37
  • IgE responsiveness, atopic

    0.37
  • exfoliative dermatitis

    0.33
  • Increased circulating IgE concentration

    0.33
  • neurodegenerative disease

    0.29
  • hereditary disease

    0.20

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Serine protease inhibitor Kazal-type 5

Serine protease inhibitor, probably important for the anti-inflammatory and/or antimicrobial protection of mucous epithelia. Contribute to the integrity and protective barrier function of the skin by regulating the activity of defense-activating and desquamation-involved proteases. Inhibits KLK5, its major target, in a pH-dependent manner. Inhibits KLK7, KLK14 CASP14, and trypsin

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.